
Investigative Cell Biology
Accelerate R&D
Improve Data Quality
Enhance Relevance
Our Services: Scalable Multi-Well Assays

Vascular Capillary Networks

Spheroids and Tumoroids

Barrier Tissues Assays
Cell-Based Assays
-
High-content cell imaging
-
Cell viability, cytotoxicity & signaling
-
2D & 3D angiogenesis in 384-well plates
-
96-well tumor spheroids for drug testing
-
96-well TEER & transport testing in barrier tissues
-
Multi-color FACS analysis
Molecular Biology
-
Chromatography for protein purification
-
Electrophoresis & Western for protein detection
-
Antigen-antibody interaction
-
DLS/SEC/MALS for particles & aggregates
-
AAV & lentivirus production
-
Analytical Ultracentrifugation
VecStem™: Endothelial Cell Growth Media

The VecStem Endothelial Cell Culture Media from Creative Scientist, Inc. is specially formulated and optimized for robust endothelial cell growth. The complete VecStem media contains 2% human serum, recombinant growth factors, and vitamins.
Core Technology
Population-wide assessment of human health
This is a challenging topic because of intrinsic genetic diversity complicated by age and other non-genetic factors, such as exposure to environmental stressors. To assess human responses to drugs and toxicants, we develop functional in vitro cell-based assays using highly primary human cells isolated from peripheral blood.
​
To study the diversity of responses to drugs and toxicants we build a collection of human progenitor cells. These cells can be used in multiple assays for population studies in a dish.

Case Study 1: Cell-Based Toxicology
Donor-Derived Progenitor Cells for Population-Wide Toxicity Testing
Environmental toxicants affect people differently. A substance harmless to one person can be toxic to another because of genetics, or previous experiences, or both. To identify such vulnerable people we are developing special assay platform utilizing donor-derived progenitor cells.

Case Study 2: Radiation Exposure
Donor-Derived Endothelial Progenitor Cells Are Sensitive to Radiation
We have developed an assay platform utilizing donor-specific endothelial progenitor cells as a proxy to test individual sensitivity to ionizing radiation (IR). IR is known to cause long-term complications. In our method, individual IR sensitivity is correlated to an in vitro response to radiation of endothelial progenitor cells, also called endothelial colony forming cells (ECFCs), which critically contribute to the healing of injured tissues. ECFC recruitment, proliferation, and differentiation have been proposed to be a key to tissue recovery after radiation-induced damage. Our assay platform helps to analyze individual susceptibility to radiation-mediated damage and enables the discovery of novel radioprotectors.
Meet Creative Scientist Team

Founder & CEO, Business and Scientific Leadership

Chief Scientist, Cell-Based Assay Development

Collaborator, Epidemiologist

Collaborator, Molecular Biology Product Development

Collaborator, High Content Imaging

Quality Assurance

Corporate Attorney

Intellectual Property

Senior Scientist

Engineer
Contact Us
104 TW Alexander Dr, Bldg 20, Ste 2020, Research Triangle Park, NC 27509
